Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The DETOURS Trial: De-escalating Empiric Treatment: Opting Out of Rx for Selected Patients With Suspected Sepsis - Opt-Out Protocol Trial

NCT03517007 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT03517007
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03517007 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The DETOURS Trial: De-escalating Empiric Treatment: Opting Out of Rx for Selected Patients With Suspected Sepsis - Opt-Out Protocol Trial
Lead sponsor
Duke University
Phase
Not applicable
Overall status
Completed
Start date
September 12, 2018
Completion date
August 10, 2020
Enrollment
762 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

antibiotic stewardship